Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 3.45 USD -12.88% Market Closed
Market Cap: 282.8m USD
Have any thoughts about
Sutro Biopharma Inc?
Write Note

Sutro Biopharma Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sutro Biopharma Inc
Net Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Sutro Biopharma Inc
NASDAQ:STRO
Net Income
-$124.5m
CAGR 3-Years
-16%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
10%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Income
$4.2B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income
$4.7B
CAGR 3-Years
-13%
CAGR 5-Years
17%
CAGR 10-Years
30%

See Also

What is Sutro Biopharma Inc's Net Income?
Net Income
-124.5m USD

Based on the financial report for Jun 30, 2024, Sutro Biopharma Inc's Net Income amounts to -124.5m USD.

What is Sutro Biopharma Inc's Net Income growth rate?
Net Income CAGR 5Y
-26%

Over the last year, the Net Income growth was 13%. The average annual Net Income growth rates for Sutro Biopharma Inc have been -16% over the past three years , -26% over the past five years .

Back to Top